Analysis – Page 282 – Goldea Capital

Brady Corporation Reports Record Adjusted EPS in its Fiscal 2026 Third Quarter and Raises its Fiscal 2026 Adjusted EPS Guidance

Written by Customer Service on May 18, 2026. Posted in Earnings Releases And Operating Results.

Sales for the quarter increased 13.8 percent compared to the same quarter of the prior year. Organic sales increased 8.2 percent, acquisitions increased sales 2.1 percent and foreign currency translation increased sales 3.5 percent. Diluted EPS increased 11.0 percent to $1.21 in the third quarter of fiscal 2026 compared to $1.09 in the same quarter of the prior year. Adjusted Diluted EPS* increased 23.0 percent to $1.50 in the third quarter of fiscal 2026 compared to $1.22 in the same quarter of the prior year. Net cash provided by operating activities increased to $78.2 million in the third quarter of fiscal 2026 compared to $59.9 million in the third quarter of last year. GAAP earnings per diluted Class A Nonvoting Common share guidance for the year ending July 31, 2026 was adjusted from the previous range of $4.62 to $4.82 per share...

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update

Written by Customer Service on May 18, 2026. Posted in Earnings Releases And Operating Results.

Key highlights from the first quarter of operations under the expanded management team include the following:Anticipated FDA decision on the Company’s ANDA for Preservative-Free Ketamine in Q3 2026, with favorable preliminary determinations already received from the FDA Office of Generic Drugs on bioequivalence, labeling, drug product, drug substance, and safety. Initiation of commercial manufacturing of Ketamine at the 1 million dose per month level with recent FDA inspection of the manufacturing facility and granting of inspection status consistent with launch of an ANDA drug. Completed a Type C meeting with the FDA Division of Psychiatry Products and CDER leadership, in which the Agency expressed openness to existing clinical trial data and Real World Evidence supporting approval without additional trials. Presidential Executive...

Onfolio Holdings Inc. Announces Q1 2026 Financial Results and Provides Corporate Update

Written by Customer Service on May 18, 2026. Posted in Earnings Releases And Operating Results.

Conference Call to Discuss Q1 2026 Results Scheduled for Today at 8:00 a.m. ET WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP) (“Onfolio” or the “Company”), an owner-operator of cash-generative online businesses, announces financial results for the first quarter ended March 31, 2026. Recent Corporate HighlightsActivated acquisition program and will target the acquisition of between $5 million and $10 million in aggregate annual adjusted EBITDA before the end of 2026. Secured a $100 million equity financing facility in April 2026 to accelerate acquisition strategy. Regained compliance with Nasdaq Listing Rule 5550(a)(2) as of May 1, 2026.First Quarter 2026 Financial HighlightsRevenue was $1.87M vs. $2.81M in Q1 2025 Gross profit decreased 46% to $0.92M, or 49% of...

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

Written by Customer Service on May 18, 2026. Posted in Earnings Releases And Operating Results.

Completed successful FDA End-of-Phase 2 meeting, reaching alignment on the study parameters of RESTORE, a registrational study of NVG-291 in chronic tetraplegia, with site activation underway and study initiation on track for mid-2026. Independent, blinded biomechanical gait analyses of the CONNECT SCI study designed to differentiate genuine neural recovery from compensatory movement remain ongoing, with results anticipated in 2Q 2026. Successfully listed on Nasdaq under the symbol ‘NGEN’ on January 8, 2026, and voluntarily delisted from the TSX Venture Exchange. Strengthened leadership team with three senior appointments to support late-stage clinical development and Nasdaq listing.VANCOUVER, British Columbia, May 18, 2026 (GLOBE NEWSWIRE) — NervGen Pharma Corp. (“NervGen” or the “Company”) (NASDAQ: NGEN),...

BingEx Secures Strategic Investment from HLID to Accelerate Drone Delivery

Written by Customer Service on May 18, 2026. Posted in Public Companies.

BEIJING, May 18, 2026 (GLOBE NEWSWIRE) — BingEx Limited (“BingEx” or the “Company”) (Nasdaq: FLX), a leading on-demand dedicated courier services provider in China (branded as “FlashEx”), today announced that its wholly-owned subsidiary has recently signed a strategic investment agreement with Hangzhou Low-Altitude Industry Development Co., Ltd. (“HLID”). Upon completion of the investment, FlashEx will become one of the first on-demand delivery companies in Hangzhou to receive strategic support from the city’s low-altitude industry platform, marking a meaningful step in the Company’s expansion into drone delivery and low-altitude logistics. FlashEx is one of China’s earliest and largest on-demand dedicated courier service providers, with more than a decade of experience in intra-city delivery and a fulfillment network covering...

iQIYI Announces First Quarter 2026 Financial Results

Written by Customer Service on May 18, 2026. Posted in Earnings Releases And Operating Results.

BEIJING, May 18, 2026 (GLOBE NEWSWIRE) — iQIYI, Inc. (Nasdaq: IQ) (“iQIYI” or the “Company”), a leading provider of online entertainment video services in China, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 HighlightsTotal revenues were RMB6.23 billion (US$902.5 million1), decreasing 13% year over year. Operating loss was RMB228.4 million (US$33.1 million) and operating loss margin was 4%, compared to operating income of RMB341.9 million and operating income margin of 5% in the same period in 2025. Non-GAAP operating loss2 was RMB148.6 million (US$21.5 million) and non-GAAP operating loss margin was 2%, compared to non-GAAP operating income of RMB458.5 million and non-GAAP operating income margin of 6% in the same period in 2025. Net loss attributable to iQIYI...

EHang Provides Investors Q&A regarding Form 6-K/A

Written by Customer Service on May 18, 2026. Posted in Public Companies.

GUANGZHOU, China, May 18, 2026 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), a global leader in advanced air mobility (“AAM”) technology, furnished a Form 6-K/A on May 15, 2026 (the “Form 6-K/A”) to provide corrected unaudited interim financial information for the second quarter, third quarter, and fourth quarter and the full fiscal year ended December 31, 2025. In response to questions from investors regarding the Form 6-K/A, the Company has provided an investor Q&A on its Investor Relations webpage at: https://ir.ehang.com/6-ka-qa. Note: This release provides supplemental background only. It does not amend or supersede any information in the Company’s Form 20-F for 2025. For a full reconciliation of these adjustments and corrected financial information, please refer to the Form 6-K/A...

Eesti Energia 5yr Senior Green Bond Mandate Announcement

Written by Customer Service on May 18, 2026. Posted in Public Companies.

Eesti Energia AS, rated Baa3 (stable) by Moody’s and BBB- (stable) Fitch, has mandated Goldman Sachs Bank Europe SE as Sole Global Coordinator and Joint Lead Manager and AS LHV Pank as Joint Lead Manager to arrange a Global Investor Call scheduled for Monday, 18th May, at 10.00am UKT / 11.00am CET as well as a series of fixed income investor calls also beginning on 18th May. A EUR-denominated 5-year Green Reg S Bearer, senior unsecured offering is expected to follow, subject to market conditions. An amount equivalent to the net proceeds from the issue of the Notes will be used to finance and/or refinance, in whole or in part, new or existing Eligible Green Projects meeting the Eligibility Criteria, each as set out in Eesti Energia’s new Green Financing Framework published in April 2026, which can be found on our website. Eesti Energia...

NEURONES: Declaration of transactions on treasury shares (May 11 to 15, 2026)

Written by Customer Service on May 18, 2026. Posted in Public Companies.

Nanterre, May 18, 2026 Declaration of transactions on treasury shares(period from May 11 to 15, 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between May 11 and 15, 2026 (ISIN code FR0004050250):Day Total daily volume(in number of shares) Weighted average price(unit daily)05/11/2026 13,671 €37.3505/12/2026 5,393 €37.3705/13/2026 5,654 €37.4605/14/2026 15,332 €37.6305/15/2026 3,625 €38.06Total 43,675 As of May 15, 2026, excluding the liquidity contract, NEURONES now holds 443,436 of the 24,328,716 shares comprising the company’s capital (i.e., 1.82%). All press releases relating to the share buyback program are published in the “Regulated Information” section (under “Weekly declarations...

Reduction of the share capital

Written by Customer Service on May 18, 2026. Posted in Public Companies.

Company announcementfor ROCKWOOL A/SRelease no. 15 – 2026to Nasdaq Copenhagen 18 May 2026 Reduction of the share capital At the Annual General Meeting of ROCKWOOL A/S (the “Company”) held on 15 April 2026, it was resolved to reduce the Company’s B share capital from nominally 113,959,672 DKK to nominally 109,613,112 DKK by cancelling a portion of the Company’s treasury B shares, corresponding to nominally 4,346,560 DKK. The Company has today completed the capital reduction and registered it with the Danish Business Authority, thus cancelling 4,346,560 B shares of 1 DKK each, corresponding to a total nominal value of 4,346,560 DKK. Following the reduction, the Company’s total share capital amounts to nominally 207,259,230 DKK, divided into a class A share capital of nominally 97,646,118 DKK and a class B share capital of nominally...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals